TP53 and carcinoma: Most of the endometrioid-like ECSs also showed TP53 mutations, implying that TP53 could be involved in the progression of part of the copy-number low endometrioid-like carcinomas to ECSs, as we have previously reported in undifferentiated endometrial carcinoma [31].